Thiopurine metabolism monitoring: implications in inflammatory bowel diseases

European Journal of Clinical Investigation
Olivier DewitXavier Roblin

Abstract

Thiopurines (TP) are widely used in the management of inflammatory bowel diseases. Side effects and inefficacy are a major concern as they lead to withdrawal of the drug. Tools investigating TP metabolism are useful to avoid inadequate cessation of TP therapy. TP metabolism is complex and many enzymes are involved. Among them, Thiopurine methyl transferase is the only one routinely measured by pheno- or genotyping. A decreased TPMT activity results in a potential overdosing of TP drugs leading to myelotoxicity, whereas an ultra-high activity leads to TP ineffectiveness and overproduction of methylated compounds responsible for hepatotoxicity. TPMT determination prior to TP treatment results in an individual adapted dose. Xanthine oxidase/dehydrogenase (XOD), inosine triphosphate pyrophosphatase (ITPA) and glutathion-S-transferase (GST) are other promising enzyme targets that might help to explain TP efficacy or toxicity. ITPA and GST polymorphisms might potentially be related to some TP side effects, while a XOD inhibition by allopurinol could avoid TP-related hepatotoxicity. Utilization of thiopurine metabolites, 6-thioguanine nucleotides and 6-methylmercaptopurine, is discussed, specifically, in case of thiopurine failure and...Continue Reading

References

Dec 1, 1992·Clinical Pharmacology and Therapeutics·M V RellingW E Evans
Dec 1, 1991·Clinical Pharmacology and Therapeutics·R GuercioliniR M Weinshilboum
Jan 1, 1996·European Journal of Clinical Pharmacology·R A LysaaJ Aarbakke
Sep 1, 1996·The Annals of Pharmacotherapy·D T KennedyK D Lake
Dec 21, 2000·Alimentary Pharmacology & Therapeutics·J R Boulton-JonesA A Mahmoud
Feb 24, 2001·Scandinavian Journal of Gastroenterology·J BelaicheE Louis
Apr 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W E EvansM V Relling
Nov 8, 2001·Journal of Pediatric Gastroenterology and Nutrition·P GuptaB S Kirschner
Nov 15, 2001·Clinical Pharmacokinetics·M Schwab, U Klotz
Feb 22, 2002·Alimentary Pharmacology & Therapeutics·O DewitY Horsmans
Sep 25, 2002·Alimentary Pharmacology & Therapeutics·A AnsariJ Sanderson
Oct 18, 2002·Human Genetics·Satoshi SumiJohn A Duley
Apr 17, 2003·The Journal of Clinical Investigation·Imke TiedeMarkus F Neurath
Jun 18, 2003·The American Journal of Gastroenterology·Marla C DubinskyEric A Vasiliauskas
Aug 2, 2003·Gastroenterology·Marla C DubinskyFred F Poordad
Aug 26, 2003·European Journal of Clinical Pharmacology·Eleni AklilluMagnus Ingelman-Sundberg
Jan 1, 1962·American Journal of Surgery·J VAN PROHASKA, N J SIDERIUS
May 1, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Carmen CuffariTheodore M Bayless
Jul 2, 2004·Therapeutic Drug Monitoring·William E Evans
Aug 10, 2004·Annals of Clinical Biochemistry·Jeremy SandersonJohn Duley
Aug 28, 2004·The American Journal of Gastroenterology·Benjamin A GoldenbergCharles N Bernstein
Nov 27, 2004·Pharmacogenetics·Richard B GearryMartin A Kennedy
Mar 18, 2005·Alimentary Pharmacology & Therapeutics·T KitiyakaraA S McIntyre
Mar 19, 2005·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·Farzana A SayaniRichard N Fedorak
Jun 14, 2005·European Journal of Clinical Pharmacology·Hua-Wen XinUlrich Klotz
Oct 20, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Markus F NeurathMatthias Schwab
Jan 25, 2006·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Zuzana ZelinkovaDaniël W Hommes
Apr 29, 2006·Journal of the European Academy of Dermatology and Venereology : JEADV·K OenderJ W Bauer
May 24, 2006·Molecular Pharmacology·Birgitta I EklundBengt Mannervik

❮ Previous
Next ❯

Citations

Feb 22, 2011·European Journal of Clinical Pharmacology·Curt Peterson
Mar 29, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Silvina S M VillanuevaAldo D Mottino
Apr 8, 2014·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Mahmoud MosliMajid Almadi
Jun 24, 2014·Clinics and Research in Hepatology and Gastroenterology·Nathalie ParetUNKNOWN network of French Pharmacovigilance Centers
Aug 10, 2015·Clinical Pharmacokinetics·Mehmet CoskunOle Haagen Nielsen
Feb 19, 2011·La Revue de médecine interne·M-A Loriot
Dec 21, 2012·International Journal of Clinical Practice·M SmithJ Sanderson
Jan 13, 2018·Basic & Clinical Pharmacology & Toxicology·Antony Citterio-QuentinRoselyne Boulieu
Apr 2, 2014·Expert Review of Gastroenterology & Hepatology·Lauren BeswickMiles P Sparrow
Jul 29, 2011·Scandinavian Journal of Gastroenterology·Ulf Hindorf, Philip Andersson
Mar 19, 2021·Journal of Crohn's & Colitis·Claudio FiocchiUNKNOWN Scientific Workshop Steering Committee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.